Furusyo N et al. |
Rapidly growing primary gastric B-cell lymphoma after eradication of Helicobacter pylori. |
1999 |
Intern. Med. |
pmid:10526942
|
Chérin P et al. |
Macrophagic myofasciitis: improvement with antibiotic therapy. |
1999 |
J. Rheumatol. |
pmid:10529163
|
Moola S et al. |
A multicenter study of grepafloxacin and clarithromycin in the treatment of patients with community-acquired pneumonia. |
1999 |
Chest |
pmid:10531162
|
Gonzalez Cueto D et al. |
[Gastric solitary plasmacytoma associated with +Helicobacter pylori infection]. |
1999 |
Acta Gastroenterol. Latinoam. |
pmid:10533659
|
Saito H et al. |
[Chemoprophylaxis against Mycobacterium avium complex infection induced in mice]. |
1999 |
Kekkaku |
pmid:10535281
|
Gisbert JP et al. |
Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10540045
|
Hammett DC and Evans MF |
Functional (non-ulcer) dyspepsia and Helicobacter pylori infection. To treat or not to treat? |
1999 |
Can Fam Physician |
pmid:10540692
|
Sassa K et al. |
Differential modulatory effects of clarithromycin on the production of cytokines by a tumor. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543765
|
Goldstein EJ et al. |
Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543769
|
Unal M et al. |
Ocular toxicity of intravitreal clarithromycin. |
1999 |
Retina (Philadelphia, Pa.) |
pmid:10546942
|
Woo PC et al. |
Antibiotics modulate vaccine-induced humoral immune response. |
1999 |
Clin. Diagn. Lab. Immunol. |
pmid:10548572
|
Adamsson I et al. |
Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. |
1999 |
J. Antimicrob. Chemother. |
pmid:10552979
|
Cirioni O et al. |
In-vitro activity of rifabutin and albendazole singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii. |
1999 |
J. Antimicrob. Chemother. |
pmid:10552982
|
Yoshida Y et al. |
Synthesis and anti-Helicobacter pylori activity of FR182024, a new cephem derivative. |
1999 |
Bioorg. Med. Chem. Lett. |
pmid:10560737
|
Valencia IC et al. |
Disseminated cutaneous Mycobacterium chelonae infection after injection of bovine embryonic cells. |
1999 |
Int. J. Dermatol. |
pmid:10561050
|
MartÃn de Argila C and Boixeda D |
[A ration proposal for the eradicating treatment of Helicobacter pylori infection]. |
1999 |
Med Clin (Barc) |
pmid:10562929
|
Adeyemi EO et al. |
The outcome of a 2-week treatment of Helicobacter pylori-positive duodenal ulcer with omeprazole-based antibiotic regimen in a region with high metronidazole resistance rate. |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10563537
|
Sharma VK et al. |
A survey of gastroenterologists' perceptions and practices related to Helicobacter pylori infection. |
1999 |
Am. J. Gastroenterol. |
pmid:10566709
|
Fattorini L et al. |
Activities of eighteen antimicrobial regimens against Mycobacterium avium infection in beige mice. |
1999 |
Microb. Drug Resist. |
pmid:10566874
|
Lamouliatte H et al. |
Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10571611
|
Stengel W |
[Sporotrichoid mycobacteriosis caused by Mycobacterium marinum]. |
1999 |
Dtsch. Med. Wochenschr. |
pmid:10572519
|
Madsen LG et al. |
Ménétrier's disease and Helicobacter pylori: normalization of gastrointestinal protein loss after eradication therapy. |
1999 |
Dig. Dis. Sci. |
pmid:10573379
|
Mach T and Zahradnik-Bilska J |
[Reinfection with Helicobacter pylori in patients with duodenal ulcer after successful eradication]. |
1999 |
Prz. Lek. |
pmid:10575912
|
Dionisio D et al. |
Encephalitis caused directly by Mycoplasma pneumoniae. |
1999 |
Scand. J. Infect. Dis. |
pmid:10576133
|
Huchon G |
How to manage the low-risk patient with lower respiratory tract infection? |
1999 |
Respiration |
pmid:10577170
|
de Luis DA et al. |
Improvement in lipid and haemostasis patterns after Helicobacter pylori infection eradication in type 1 diabetic patients. |
1999 |
Clin Nutr |
pmid:10578022
|
Tanigawara Y et al. |
CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori. |
1999 |
Clin. Pharmacol. Ther. |
pmid:10579481
|
Tomioka H et al. |
Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10582897
|
Komatsu H et al. |
Mycobacterium avium infection of the skin associated with lichen scrofulosorum: report of three cases. |
1999 |
Br. J. Dermatol. |
pmid:10583068
|
Semret M et al. |
Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler. |
1999 |
Am. J. Trop. Med. Hyg. |
pmid:10586895
|
Nasu T et al. |
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains]. |
1999 |
Jpn J Antibiot |
pmid:10587879
|
Langan CE et al. |
Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis. |
1999 |
J. Antimicrob. Chemother. |
pmid:10588313
|
Rodvold KA |
Clinical pharmacokinetics of clarithromycin. |
1999 |
Clin Pharmacokinet |
pmid:10589373
|
Franzin L et al. |
Clarithromycin and amoxicillin susceptibility of Helicobacter pylori strains isolated from adult patients with gastric or duodenal ulcer in Italy. |
2000 |
Curr. Microbiol. |
pmid:10594221
|
Dani R et al. |
Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10594400
|
Harris A |
The importance of clarithromycin dose in the management of H. pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10594406
|
Gomollón F et al. |
Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton-pump inhibitor-based therapy: a detailed, prospective analysis of 21 consecutive cases. |
1999 |
Helicobacter |
pmid:10597390
|
Uygun A et al. |
The effect of Helicobacter pylori eradication on duodenal gastric metaplasia. |
1999 Jul-Aug |
J. Int. Med. Res. |
pmid:10599027
|
Auclair B et al. |
Potential interaction between itraconazole and clarithromycin. |
1999 |
Pharmacotherapy |
pmid:10600094
|
Feldman M et al. |
Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux. |
1999 |
Am. J. Physiol. |
pmid:10600812
|
Raderer M et al. |
Regression of colonic low grade B cell lymphoma of the mucosa associated lymphoid tissue type after eradication of Helicobacter pylori. |
2000 |
Gut |
pmid:10601069
|
Sainz R et al. |
[Helicobacter pylori infection. The Spanish consensus report. The Spanish Consensus Conference Group]. |
1999 |
Rev Esp Enferm Dig |
pmid:10601771
|
Tanaka G et al. |
Effect of clarithromycin on Pseudomonas aeruginosa biofilms. |
2000 Jan-Feb |
Chemotherapy |
pmid:10601796
|
Hamada K et al. |
Adjuvant effect of clarithromycin on chemotherapy for murine lung cancer. |
2000 Jan-Feb |
Chemotherapy |
pmid:10601798
|
Fernández-Roblas R et al. |
In vitro susceptibilities of rapidly growing mycobacteria to telithromycin (HMR 3647) and seven other antimicrobials. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10602744
|
Ku YY et al. |
Synthesis and antibacterial activities of novel 12-O-methylerythromycin A derivatives. |
1999 |
J. Antibiot. |
pmid:10604761
|
Ianaro A et al. |
Anti-inflammatory activity of macrolide antibiotics. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10604943
|
Suzuki K et al. |
Effect of proton pump inhibitor alone or in combination with clarithromycin on mycobacterial growth in human alveolar macrophages. |
2000 |
FEMS Microbiol. Lett. |
pmid:10612733
|
Giacometti A et al. |
In vitro anticryptosporidial activity of ranalexin alone and in combination with other peptides and with hydrophobic antibiotics. |
1999 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:10614961
|
Midolo PD et al. |
In vitro synergy between ranitidine bismuth citrate and tetracycline or clarithromycin against resistant strains of Helicobacter pylori. |
1999 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:10614963
|
Abe S et al. |
Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells. |
2000 |
Am. J. Respir. Cell Mol. Biol. |
pmid:10615065
|
Kiyota K et al. |
Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial. |
1999 |
J. Gastroenterol. |
pmid:10616771
|
Aoyama N et al. |
Sufficient effect of 1-week omeprazole and amoxicillin dual treatment for Helicobacter pylori eradication in cytochrome P450 2C19 poor metabolizers. |
1999 |
J. Gastroenterol. |
pmid:10616772
|
Gotoda T et al. |
Endoscopic and histological reversibility of gastric adenoma after eradication of Helicobacter pylori. |
1999 |
J. Gastroenterol. |
pmid:10616774
|
Maeda S et al. |
Detection of clarithromycin-resistant helicobacter pylori strains by a preferential homoduplex formation assay. |
2000 |
J. Clin. Microbiol. |
pmid:10618089
|
Rocha RT et al. |
Comparison of spiramycin and clarithromycin for community-acquired lower respiratory tract infections. |
1999 |
Int. J. Clin. Pract. |
pmid:10622070
|
Lugannani C and Strickland C |
Empiric eradication therapy or endoscopy in Helicobacter pylori-positive patients? |
1999 |
J Fam Pract |
pmid:10628582
|
Bui KQ et al. |
In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa. |
2000 |
J. Antimicrob. Chemother. |
pmid:10629013
|
Blondon H |
[Eradication of Helicobacter pylori: what is the effect on symptoms of non-ulcerous dyspepsia?]. |
1999 |
Presse Med |
pmid:10629694
|
Cammarota G et al. |
Six-day or seven-day regimens with ranitidine bismuth citrate plus high-dose clarithromycin and tinidazole are both effective against Helicobacter pylori infection. |
1999 |
Dig. Dis. Sci. |
pmid:10630486
|
Bortolotti M et al. |
Effect of intravenous clarithromycin on interdigestive gastroduodenal motility of patients with functional dyspepsia and Helicobacter pylori gastritis. |
1999 |
Dig. Dis. Sci. |
pmid:10630494
|
Burgess DS et al. |
A time-kill evaluation of clarithromycin and azithromycin against two extracellular pathogens and the development of resistance. |
1999 |
Ann Pharmacother |
pmid:10630825
|
Juurlink DN and Ito S |
Comment: clarithromycin-digoxin interaction. |
1999 |
Ann Pharmacother |
pmid:10630847
|
Hoshiya S et al. |
Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan. |
2000 |
J. Gastroenterol. |
pmid:10632534
|
Fujioka T |
Clarithromycin resistance in Helicobacter pylori: implications for therapy. |
2000 |
J. Gastroenterol. |
pmid:10632546
|
Bardhan KD et al. |
Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10632646
|
Vcev A et al. |
Pantoprazole, amoxycillin and either azithromycin or clarithromycin for eradication of Helicobacter pylori in duodenal ulcer. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10632647
|
Cammarota G et al. |
Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10632648
|
Gasbarrini A et al. |
Efficacy of a multistep strategy for Helicobacter pylori eradication. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10632649
|
Chan FK et al. |
Salvage therapies after failure of Helicobacter pylori eradication with ranitidine bismuth citrate-based therapies. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10632651
|
Iakovlev VP |
[New semisynthetic macrolides. Clarithromycin--its importance in the current therapy of bacterial infections]. |
1999 |
Antibiot. Khimioter. |
pmid:10635418
|
Keiser P et al. |
A retrospective study of the addition of ciprofloxacin to clarithromycin and ethambutol in the treatment of disseminated Mycobacterium avium complex infection. |
1999 |
Int J STD AIDS |
pmid:10639059
|
Miyanohara T et al. |
Effects of clarithromycin on cultured human nasal epithelial cells and fibroblasts. |
2000 |
Laryngoscope |
pmid:10646728
|
Graham DY et al. |
Furazolidone combination therapies for Helicobacter pylori infection in the United States. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10651662
|
Wong BC et al. |
Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10651663
|
Fock KM et al. |
Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: results of a multicentre study in South-East Asia. South-East Asia Multicenter Study Group. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10651664
|
Chiba N and Marshall CP |
Omeprazole once or twice daily with clarithromycin and metronidazole for Helicobacter pylori. |
2000 |
Can. J. Gastroenterol. |
pmid:10655024
|
Alarcón T et al. |
PCR using 3'-mismatched primers to detect A2142C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates. |
2000 |
J. Clin. Microbiol. |
pmid:10655418
|
Allevi P et al. |
A new convenient transformation of erythromycin A into clarithromycin. |
1999 |
Bioorg. Med. Chem. |
pmid:10658579
|
Yatsunami J et al. |
Roxithromycin and clarithromycin, 14-membered ring macrolides, potentiate the antitumor activity of cytotoxic agents against mouse B16 melanoma cells. |
1999 |
Cancer Lett. |
pmid:10660084
|
Hoshi T et al. |
Cell damage and proliferation in human gastric mucosa infected by Helicobacter pylori--a comparison before and after H pylori eradication in non-atrophic gastritis. |
1999 |
Hum. Pathol. |
pmid:10667417
|
Mordi MN et al. |
Acid-catalyzed degradation of clarithromycin and erythromycin B: a comparative study using NMR spectroscopy. |
2000 |
J. Med. Chem. |
pmid:10669574
|
Griffith DE et al. |
Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex. |
2000 |
Clin. Infect. Dis. |
pmid:10671330
|
Miyabayashi H et al. |
Influence of oral Helicobacter pylori on the success of eradication therapy against gastric Helicobacter pylori. |
2000 |
Helicobacter |
pmid:10672049
|
Dammann HG et al. |
Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration. |
2000 |
Helicobacter |
pmid:10672051
|
Calvet X et al. |
Four-day, twice daily, quadruple therapy with amoxicillin, clarithromycin, tinidazole and omeprazole to cure Helicobacter pylori infection: a pilot study. |
2000 |
Helicobacter |
pmid:10672052
|
Sevin E et al. |
[Helicobacter pylori: identification and detection of clarithromycin resistance by gene amplification]. |
2000 Jan-Feb |
Ann. Biol. Clin. (Paris) |
pmid:10673617
|
Kohri K et al. |
Macrolide antibiotics inhibit nitric oxide generation by rat pulmonary alveolar macrophages. |
2000 |
Eur. Respir. J. |
pmid:10678622
|
Jung R et al. |
Postantibiotic effects and bactericidal activities of clarithromycin-14-hydroxy-clarithromycin, versus those of amoxicillin-clavulanate, against anaerobes. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10681358
|
Suleymanlar I et al. |
Response to triple treatment with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori infections in continuous ambulatory peritoneal dialysis patients. |
1999 |
Adv Perit Dial |
pmid:10682076
|
Sugimoto M et al. |
Prevention of hemorrhage from intradiverticular ulcer in the duodenum by Helicobacter pylori eradication. |
2000 |
Am. J. Gastroenterol. |
pmid:10685780
|
Gotfried MH |
Comparison of bacteriologic eradication of Streptococcus pneumoniae by clarithromycin and reports of increased antimicrobial resistance. |
2000 |
Clin Ther |
pmid:10688386
|
Bayerdörffer E |
[The MACH2 Study: value of inhibiting gastric acid secretion in eradication of Helicobacter pylori with a one week triple therapy protocol]. |
2000 |
Z Gastroenterol |
pmid:10689750
|
Szlachcic A et al. |
Helicobacter pylori and its eradication in rosacea. |
1999 |
J. Physiol. Pharmacol. |
pmid:10695558
|
Georgopoulos SD et al. |
Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole, amoxicillin, and clarithromycin. |
2000 |
Dig. Dis. Sci. |
pmid:10695615
|
Dore MP et al. |
Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach. |
2000 |
Dig. Dis. Sci. |
pmid:10695616
|
Miwa H et al. |
Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection: comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole. |
2000 |
Dig. Dis. Sci. |
pmid:10695617
|
Shamaly H et al. |
Efficacy of bismuth-based triple therapy in children with abdominal pain and Helicobacter pylori gastritis. |
2000 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:10697140
|
Ives TJ et al. |
In vitro susceptibilities of Rickettsia and Bartonella spp. to 14-hydroxy-clarithromycin as determined by immunofluorescent antibody analysis of infected vero cell monolayers. |
2000 |
J. Antimicrob. Chemother. |
pmid:10702548
|
Schweeger I et al. |
Successful eradication of Helicobacter pylori as determined by ((13))C-urea breath test does not alter fibrinogen and acute phase response markers. |
2000 |
Thromb. Res. |
pmid:10704650
|